Sort   by:  
 Page size 
UnknownSpatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Not available
S-EPMC6890490 | biostudies-literature
UnknownExploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.
Not available
S-EPMC12170883 | biostudies-literature
UnknownA clonal expression biomarker associates with lung cancer mortality.
Not available
S-EPMC6984959 | biostudies-literature
UnknownNeoantigen-directed immune escape in lung cancer evolution.
Not available
S-EPMC6954100 | biostudies-literature
UnknownThe T cell differentiation landscape is shaped by tumour mutations in lung cancer.
Not available
S-EPMC7115931 | biostudies-literature
UnknownAllele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Not available
S-EPMC5720478 | biostudies-literature
UnknownDevelopment and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.
Not available
S-EPMC7832571 | biostudies-literature
UnknownCo-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Not available
S-EPMC8172149 | biostudies-literature
UnknownThe evolution of lung cancer and impact of subclonal selection in TRACERx.
Not available
S-EPMC10115649 | biostudies-literature
UnknownCovered versus uncovered endoluminal stenting in the acute management of obstructing colorectal cancer in the palliative setting: randomized clinical trial (CReST2).
Not available
S-EPMC12448851 | biostudies-literature
Sort   by:  
 Page size